BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16013944)

  • 1. [Efficacy and safety of misoprostol in obstetrics].
    Capilla Montes C; Bermejo Vicedo T
    Farm Hosp; 2005; 29(3):177-84. PubMed ID: 16013944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misoprostol and pregnancy: ever-increasing indications of effective usage.
    Lokugamage AU; Refaey HE; Rodeck CH
    Curr Opin Obstet Gynecol; 2003 Dec; 15(6):513-8. PubMed ID: 14624219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of misoprostol in gynecology and obstetrics].
    Béchard de Spirlet M
    Gynecol Obstet Fertil; 2002 Apr; 30(4):317-24. PubMed ID: 12043508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misoprostol and pregnancy.
    Goldberg AB; Greenberg MB; Darney PD
    N Engl J Med; 2001 Jan; 344(1):38-47. PubMed ID: 11136959
    [No Abstract]   [Full Text] [Related]  

  • 5. Cervical preparation for first trimester surgical abortion.
    Kapp N; Lohr PA; Ngo TD; Hayes JL
    Cochrane Database Syst Rev; 2010 Feb; (2):CD007207. PubMed ID: 20166091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT; Sukcharoen N; Thong KJ
    Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Misoprostol--a new prostaglandin in obstetrical practice].
    Katsulov A; Todorova Ts
    Akush Ginekol (Sofiia); 1998; 37(2):59-66. PubMed ID: 9859543
    [No Abstract]   [Full Text] [Related]  

  • 8. [Misoprostol in gynecology and obstetrics].
    Halmesmäki E; Nuutila M
    Duodecim; 1998; 114(14):1422-4. PubMed ID: 11552252
    [No Abstract]   [Full Text] [Related]  

  • 9. Misoprostol: a quarter century of use, abuse, and creative misuse.
    Chong YS; Su LL; Arulkumaran S
    Obstet Gynecol Surv; 2004 Feb; 59(2):128-40. PubMed ID: 14752301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misoprostol versus cervagem for the induction of labour to terminate pregnancy in the second and third trimester: a systematic review.
    Dodd JM; Crowther CA
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):3-8. PubMed ID: 16466671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview and expert assessment of off-label use of misoprostol in obstetrics and gynaecology: review and report by the Collège national des gynécologues obstétriciens français.
    Marret H; Simon E; Beucher G; Dreyfus M; Gaudineau A; Vayssière C; Lesavre M; Pluchon M; Winer N; Fernandez H; Aubert J; Bejan-Angoulvant T; Jonville-Bera AP; Clouqueur E; Houfflin-Debarge V; Garrigue A; Pierre F;
    Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():80-4. PubMed ID: 25701235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO recommendations for misoprostol use for obstetric and gynecologic indications.
    Tang J; Kapp N; Dragoman M; de Souza JP
    Int J Gynaecol Obstet; 2013 May; 121(2):186-9. PubMed ID: 23433680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation.
    Bartley J; Brown A; Elton R; Baird DT
    Hum Reprod; 2001 Oct; 16(10):2098-102. PubMed ID: 11574498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial.
    Wong KS; Ngai CS; Wong AY; Tang LC; Ho PC
    Contraception; 1998 Oct; 58(4):207-10. PubMed ID: 9866000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misoprostol use during the third stage of labor.
    Joy SD; Sanchez-Ramos L; Kaunitz AM
    Int J Gynaecol Obstet; 2003 Aug; 82(2):143-52. PubMed ID: 12873774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of fever after misoprostol for the prevention of postpartum hemorrhage: a meta-analysis.
    Elati A; Weeks A
    Obstet Gynecol; 2012 Nov; 120(5):1140-8. PubMed ID: 23090533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misoprostol for induction of labour: a systematic review.
    Hofmeyr GJ; Gülmezoglu AM; Alfirevic Z
    Br J Obstet Gynaecol; 1999 Aug; 106(8):798-803. PubMed ID: 10453829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandins for management of retained placenta.
    Grillo-Ardila CF; Ruiz-Parra AI; Gaitán HG; Rodriguez-Malagon N
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD010312. PubMed ID: 24833288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians' approaches to post-abortion care in Manila, Philippines.
    Cansino C; Melgar JL; Burke A
    Int J Gynaecol Obstet; 2010 Jun; 109(3):216-8. PubMed ID: 20176351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.